The nation’s longest government shutdown ended Wednesday meaning SNAP can resume payments. Newsweek's live blog is closed.

The U.S. fund overseeing U.S. President Donald Trump's critical minerals deal with Ukraine said on Friday it had appointed advisory firm Alvarez & Marsal to help it identify and size up potential ...

Marks and Spencer is selling two slices of bread, specifically its Spanish Pan de Cristal product, for up to £4.50. Money reporter Jess Sharp brings you this and the rest of today's consumer and ...

Perfect Moment Ltd. (NYSE American: PMNT) ("Perfect Moment" or the "Company"), the high-performance, luxury lifestyle brand that fuses technical excellence with fashion-led designs, reported results ...

Net Loss -- Net loss for Q3 2025 was $2.3 million compared to a $6.9 million loss in Q3 2024, driven by higher gross profit, reduced operating expenses, and partially offset by higher interest expense ...

Agroz Inc. ("Agroz," the "Company," "we," "us," or "our"), an innovative, fully vertically integrated agricultural technology company specializing in AI-powered Controlled Environment Agriculture ...

Chelsea’s January Midfield Plans Take Shape Amid Injury ConcernsChelsea’s hierarchy are preparing for an active January ...

The QSTTM substrate*1, a 300-mm GaN growth substrate that Shin-Etsu Chemical Co., Ltd. (Head Office: Tokyo; President: Yasuhiko ...

This platform’s AI engine translates natural language questions into complex SQL queries, returning answers as visual charts ...

Kopin Corporation ("Kopin" or "the Company") (Nasdaq: KOPN), a leading developer and provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays, ...

At current prices, ARC Resources offers an 11% annual return under conservative assumptions. See here to know why ARX is ...

MRT-8102 is a selective, potent, and durable NEK7 degrader. Activation of the NLRP3 inflammasome critically depends on NEK7. Administration of MRT-8102 led to inhibition of NLRP3 inflammasome in vitro ...